Interactions due to inhibition of monoamine oxidase A (MAO-A) or MAO-B were extensively studied due to the historical use of MAO inhibitors as therapeutic agents, originally in the treatment of depression and later in the management of affective and neurological disorders, stroke, and aging-related neurocognitive changes [19]. Here, MAOB is linked to depressive disorder.